FSC
ABBV icon

Full Sail Capital’s AbbVie ABBV Stock Holding History

Full Sail Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$510K Hold
2,202
– – 0.03% 154
2025
Q2 		$409K Buy
2,202
+1,050
+91% +$195K 0.02% 141
2025
Q1 		$241K Buy
+1,152
New +$224K 0.02% 151
2023
Q1 		– Sell
-1,449
Closed -$234K – 147
2022
Q4 		$234K Buy
+1,449
New +$222K 0.02% 128
2019
Q1 		– Sell
-2,565
Closed -$236K – 144
2018
Q4 		$236K Buy
+2,565
New +$226K 0.11% 108

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Full Sail Capital's ABBV Position: Q3 2025 in Review

Full Sail Capital held its AbbVie (ABBV) position steady in Q3 2025 at 2,202 shares worth $510K. The position accounts for 0.03% of the portfolio, ranked #154.

Full Sail Capital first reported a position in ABBV in Q4 2018 and has held it in 5 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Full Sail Capital held 2,202 shares of AbbVie worth $510K as of Q3 2025.
  • Full Sail Capital left its AbbVie share count unchanged in Q3 2025.
  • AbbVie made up 0.03% of Full Sail Capital's portfolio in Q3 2025, its #154 holding.
  • Full Sail Capital first reported a position in AbbVie in Q4 2018 and has held it in 5 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Full Sail Capital's 13F filing for Q3 2025, filed 14 Nov 2025.